Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Debt Ratio: 2013-2024

Historic Debt Ratio for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Dec 2024 value amounting to 0.38.

  • Amphastar Pharmaceuticals' Debt Ratio fell 5.27% to 0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year decrease of 5.27%. This contributed to the annual value of 0.38 for FY2024, which is 2.17% down from last year.
  • According to the latest figures from FY2024, Amphastar Pharmaceuticals' Debt Ratio is 0.38, which was down 2.17% from 0.39 recorded in FY2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Debt Ratio peaked at 0.39 during FY2023, and registered a low of 0.07 during FY2020.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Debt Ratio value was 0.38 (recorded in 2024), while the average stood at 0.29.
  • Its Debt Ratio has fluctuated over the past 5 years, first declined by 10.78% in 2022, then skyrocketed by 281.32% in 2023.
  • Yearly analysis of 5 years shows Amphastar Pharmaceuticals' Debt Ratio stood at 0.07 in 2020, then skyrocketed by 55.78% to 0.11 in 2021, then decreased by 10.78% to 0.10 in 2022, then soared by 281.32% to 0.39 in 2023, then dropped by 2.17% to 0.38 in 2024.